Treatment Response and Resistance in Schizophrenia
Herausgeber: Howes, Oliver
Treatment Response and Resistance in Schizophrenia
Herausgeber: Howes, Oliver
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Part of the Oxford Psychiatry Library, this practical pocket book is an invaluable resource and quick reference for clincians.
Andere Kunden interessierten sich auch für
- David J CastleSchizophrenia and Psychiatric Comorbidities49,99 €
- Brenda A. LefrançoisPsychiatry Disrupted: Theorizing Resistance and Crafting the (R)Evolution40,99 €
- Ralph Sanchez MtcmThe Diabetic Brain in Alzheimer's Disease: How Insulin Resistance in Type 2 Diabetes and "Type 3 Diabetes" Triggers Your Risk for Alzheimer's and How17,99 €
- Schizophrenia and Psychotic Spectrum Disorders155,99 €
- Children and Young People's Response to Parental Illness91,99 €
- Comprehensive Care of Schizophrenia178,99 €
- Schizophrenia and Psychoses in Later Life83,99 €
-
-
-
Part of the Oxford Psychiatry Library, this practical pocket book is an invaluable resource and quick reference for clincians.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Hurst & Co.
- Seitenzahl: 218
- Erscheinungstermin: 20. Oktober 2018
- Englisch
- Abmessung: 213mm x 137mm x 13mm
- Gewicht: 295g
- ISBN-13: 9780198828761
- ISBN-10: 0198828764
- Artikelnr.: 54429118
- Verlag: Hurst & Co.
- Seitenzahl: 218
- Erscheinungstermin: 20. Oktober 2018
- Englisch
- Abmessung: 213mm x 137mm x 13mm
- Gewicht: 295g
- ISBN-13: 9780198828761
- ISBN-10: 0198828764
- Artikelnr.: 54429118
Oliver Howes, King's College London, London, Professor of Molecular Psychiatry
* 1: Oliver Howes: Introduction * 2: Robert McCutcheon
Christoph Correll
Oliver Howes
and John Kane: Treatment response and resistance in schizophrenia: principles and definition * 3: Robert C. Smith
Stefan Leucht
and John M. Davis: Maximizing response to first-line antipsychotics in Schizophrenia * 4: John Lally and James H. MacCabe: Epidemiology
impact and predictors of treatment resistant schizophrenia * 5: Stephen J. Kaar
Steven Potkin
and Oliver Howes: The neurobiology of antipsychotic treatment response and resistance * 6: Yvonne S. Yang
and Stephen R. Marder: Pharmacological management of TRS: Fundamentals of clozapine * 7: Christopher Rohde and Jimmi Nielsen: Managing common adverse-effect of clozapine * 8: Siobhan Gee and David Taylor: Pharmacological management of treatment-resistant schizophrenia: advanced use of clozapine * 9: Thomas R. E. Barnes: Pharmacological management of TRS: alternatives to clozapine * 10: Juliana Onwumere and Elizabeth Kuipers: Psychosis and the family: the role of family interventions * 11: Majella Byrne
Suzanne Jolley and Emmanuelle Peters: Cognitive behavioral therapy for psychosis * 12: Gary Remington
Ofer Agid
Hiroyoshi Takeuchi
Jimmy Lee
Araba Chintoh: Ultra treatment resistance * 13: Ofer Agid
Thomas Barnes
Majella Byrne
Araba Chintoh
Christoph Correll
Siobhan Gee
Oliver Howes
Suzanne Jolley
John Lally
Jimmy Lee
John Kane
James MacCabe
Stephen R. Marder
Robert McCutcheon
Jimmi Nielsen
Emmanuelle Peters
Gary Remington
Christopher Rohde
Hiroyoshi Takeuchi
David Taylor
and Yvonne S. Yang: Illustrative case studies * 14: Seiya Miyamoto and Nobumi Miyake: Novel treatments and future directions
Christoph Correll
Oliver Howes
and John Kane: Treatment response and resistance in schizophrenia: principles and definition * 3: Robert C. Smith
Stefan Leucht
and John M. Davis: Maximizing response to first-line antipsychotics in Schizophrenia * 4: John Lally and James H. MacCabe: Epidemiology
impact and predictors of treatment resistant schizophrenia * 5: Stephen J. Kaar
Steven Potkin
and Oliver Howes: The neurobiology of antipsychotic treatment response and resistance * 6: Yvonne S. Yang
and Stephen R. Marder: Pharmacological management of TRS: Fundamentals of clozapine * 7: Christopher Rohde and Jimmi Nielsen: Managing common adverse-effect of clozapine * 8: Siobhan Gee and David Taylor: Pharmacological management of treatment-resistant schizophrenia: advanced use of clozapine * 9: Thomas R. E. Barnes: Pharmacological management of TRS: alternatives to clozapine * 10: Juliana Onwumere and Elizabeth Kuipers: Psychosis and the family: the role of family interventions * 11: Majella Byrne
Suzanne Jolley and Emmanuelle Peters: Cognitive behavioral therapy for psychosis * 12: Gary Remington
Ofer Agid
Hiroyoshi Takeuchi
Jimmy Lee
Araba Chintoh: Ultra treatment resistance * 13: Ofer Agid
Thomas Barnes
Majella Byrne
Araba Chintoh
Christoph Correll
Siobhan Gee
Oliver Howes
Suzanne Jolley
John Lally
Jimmy Lee
John Kane
James MacCabe
Stephen R. Marder
Robert McCutcheon
Jimmi Nielsen
Emmanuelle Peters
Gary Remington
Christopher Rohde
Hiroyoshi Takeuchi
David Taylor
and Yvonne S. Yang: Illustrative case studies * 14: Seiya Miyamoto and Nobumi Miyake: Novel treatments and future directions
* 1: Oliver Howes: Introduction * 2: Robert McCutcheon
Christoph Correll
Oliver Howes
and John Kane: Treatment response and resistance in schizophrenia: principles and definition * 3: Robert C. Smith
Stefan Leucht
and John M. Davis: Maximizing response to first-line antipsychotics in Schizophrenia * 4: John Lally and James H. MacCabe: Epidemiology
impact and predictors of treatment resistant schizophrenia * 5: Stephen J. Kaar
Steven Potkin
and Oliver Howes: The neurobiology of antipsychotic treatment response and resistance * 6: Yvonne S. Yang
and Stephen R. Marder: Pharmacological management of TRS: Fundamentals of clozapine * 7: Christopher Rohde and Jimmi Nielsen: Managing common adverse-effect of clozapine * 8: Siobhan Gee and David Taylor: Pharmacological management of treatment-resistant schizophrenia: advanced use of clozapine * 9: Thomas R. E. Barnes: Pharmacological management of TRS: alternatives to clozapine * 10: Juliana Onwumere and Elizabeth Kuipers: Psychosis and the family: the role of family interventions * 11: Majella Byrne
Suzanne Jolley and Emmanuelle Peters: Cognitive behavioral therapy for psychosis * 12: Gary Remington
Ofer Agid
Hiroyoshi Takeuchi
Jimmy Lee
Araba Chintoh: Ultra treatment resistance * 13: Ofer Agid
Thomas Barnes
Majella Byrne
Araba Chintoh
Christoph Correll
Siobhan Gee
Oliver Howes
Suzanne Jolley
John Lally
Jimmy Lee
John Kane
James MacCabe
Stephen R. Marder
Robert McCutcheon
Jimmi Nielsen
Emmanuelle Peters
Gary Remington
Christopher Rohde
Hiroyoshi Takeuchi
David Taylor
and Yvonne S. Yang: Illustrative case studies * 14: Seiya Miyamoto and Nobumi Miyake: Novel treatments and future directions
Christoph Correll
Oliver Howes
and John Kane: Treatment response and resistance in schizophrenia: principles and definition * 3: Robert C. Smith
Stefan Leucht
and John M. Davis: Maximizing response to first-line antipsychotics in Schizophrenia * 4: John Lally and James H. MacCabe: Epidemiology
impact and predictors of treatment resistant schizophrenia * 5: Stephen J. Kaar
Steven Potkin
and Oliver Howes: The neurobiology of antipsychotic treatment response and resistance * 6: Yvonne S. Yang
and Stephen R. Marder: Pharmacological management of TRS: Fundamentals of clozapine * 7: Christopher Rohde and Jimmi Nielsen: Managing common adverse-effect of clozapine * 8: Siobhan Gee and David Taylor: Pharmacological management of treatment-resistant schizophrenia: advanced use of clozapine * 9: Thomas R. E. Barnes: Pharmacological management of TRS: alternatives to clozapine * 10: Juliana Onwumere and Elizabeth Kuipers: Psychosis and the family: the role of family interventions * 11: Majella Byrne
Suzanne Jolley and Emmanuelle Peters: Cognitive behavioral therapy for psychosis * 12: Gary Remington
Ofer Agid
Hiroyoshi Takeuchi
Jimmy Lee
Araba Chintoh: Ultra treatment resistance * 13: Ofer Agid
Thomas Barnes
Majella Byrne
Araba Chintoh
Christoph Correll
Siobhan Gee
Oliver Howes
Suzanne Jolley
John Lally
Jimmy Lee
John Kane
James MacCabe
Stephen R. Marder
Robert McCutcheon
Jimmi Nielsen
Emmanuelle Peters
Gary Remington
Christopher Rohde
Hiroyoshi Takeuchi
David Taylor
and Yvonne S. Yang: Illustrative case studies * 14: Seiya Miyamoto and Nobumi Miyake: Novel treatments and future directions